✦ LIBER ✦

Licensure of Gemtuzumab Ozogamicin for the Treatment of Selected Patients 60 Years of Age or Older with Acute Myeloid Leukemia in First Relapse

✍ Scribed by Mark S. Berger; Lance H. Leopold; James A. Dowell; Joan M. Korth-Bradley; Matthew L. Sherman

Book ID: 110398054
Publisher: Springer US
Year: 2002
Tongue: English
Weight: 141 KB
Volume: 20
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1020658028082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemtuzumab ozogamicin as first-line trea

Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemia

✍ Wassim McHayleh; Kenneth Foon; Robert Redner; Rajesh Sehgal; Anastasios Raptis; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Antibody-targeted chemotherapy of older

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

✍ Larson, R A; Boogaerts, M; Estey, E; Karanes, C; Stadtmauer, E A; Sievers, E L; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 163 KB

The role of gemtuzumab ozogamicin in com

The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia

✍ Hien K. Duong; Matt Kalaycio 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 178 KB

Salvage treatment for children with refr

Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study

✍ Christian M. Zwaan; Dirk Reinhardt; Martin Zimmerman; Henrik Hasle; Jan Stary; B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Final report of the efficacy and safety

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

✍ Richard A. Larson; Eric L. Sievers; Edward A. Stadtmauer; Bob Löwenberg; Elihu H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

Fractionated doses of gemtuzumab ozogami

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association

✍ Hassan Farhat; Oumedaly Reman; Emmanuel Raffoux; Celine Berthon; Cécile Pautas; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views